Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
14-day Modified Sequential Therapy for Refractory H. pylori
NCT03616405Phase 4Unknown
- Sponsor
- Shandong University
- Start
- Apr 2019
- Primary completion
- Nov 2019
- Modality
- Polymer-based Nanoparticles, DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of rabeprazole, amoxicillin, tetracycline, furazolidone, colloidal bismuth pectin in Helicobacter pylori infection, sponsored by Shandong University. Status: unknown.
02
Drugs
rabeprazoleamoxicillintetracyclinefurazolidonecolloidal bismuth pectin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03616405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03616405.